Voyageur Pharmaceuticals Ltd. VYYRF
Set alert
0.02 USD 0.00 0.00%
At close · Oct 30
0.087 Day range 0.087
0.0033 52-week range 1.03
- YTD
- -84.63%
- 1 year
- -81.65%
- Open
- 0.087
- Prev close
- 0.02
- Mkt cap
- 3.59M
- Vol
- 11.50K
- Avg vol
- 34.43K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.087
- High
- 0.087
3M chart
Signals (22)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 4, 2026 | 1 month ago |
| RSI: Overbought | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| RSI: Oversold | Sep 3, 2026 | 2 months ago |
| RSI: Overbought | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| RSI: Overbought | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
News
- Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement
- Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt
- Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment
- Voyageur Pharmaceuticals Advances Mueller Iodine Extraction Process with 99.8% Purity Results and Planned Field Pilot Testing
- Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker
- Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility
- Voyageur Pharmaceuticals Evaluating Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility, a Multi-Phase Investment Expected to Generate Significant Economic Impact and High-Skilled Jobs; Competitive Site Selection Process Underway
- Voyageur Pharmaceuticals Ltd. Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support at Frances Creek Barite Project
- Voyageur Announces Closing Of Non-Brokered Private Placement Pursuant To Listed Issuer Financing Exemption
- Voyageur Announces Update To Non-Brokered Life Offering
Your note
Sign in to keep a note on VYYRF — it syncs with the Stock Master app.